title: Anxiolytic-like action in mice treated with nitrous oxide and oral triazolam or diazepam.
abstract: Few animal studies have explored the interaction of nitrous oxide (N2O) with a benzodiazepine (BNZ) administered by the oral route, as used in clinical procedures involving "conscious sedation". The purpose of this study was to evaluate the relative "anxiolytic-like" and sedative effectiveness of N2O, oral triazolam (TRIAZ; Halcion) or oral diazepam (DIAZ; Valium), either alone or in various combinations of drugs and doses. One hundred and twelve Swiss Webster male mice, 35-45 days old, were assigned to 28 groups, each of which contained four mice. The mouse staircase test was used for the assessment of anxiety (number of rearings) and sedation (number of steps ascended). Three doses of oral TRIAZ (0.1, 0.3, 1.0 mg/kg) or DIAZ (2.0, 3.5, 5.0 mg/kg) were given in combination with room air, or N2O/O2 at a N2O concentration of 25, 50 or 75%. Each mouse was tested once. N2O alone did not reduce NR in any concentration, but caused a significant increase in locomotion. DIAZ without N2O reduced NR only with the middle and high doses, but the addition of N2O significantly enhanced the anxiolytic-like effect of all DIAZ doses. TRIAZ, alone, reduced NR only in the highest dose, but added N2O resulted in anxiolytic-like behavior with all three TRIAZ doses. The sedative effects of the BNZs were extremely variable. Only the middle dose of DIAZ plus 25% N2O unequivocally reduced the number of steps ascended, i.e., caused sedation. TRIAZ lacked the inverted U-shaped dose-response relationship with NR usually seen with DIAZ. TRIAZ, therefore, provides better dose control. This behavioral animal model indicates that the optimal combinations for reduction of anxiety-like behavior with minimal effects on sedation are 0.1 mg/kg oral TRIAZ with 25% N2O or 2.0 mg/kg oral DIAZ with 25% N2O.
authors.affiliation: Department of Pediatric Dentistry, UMDNJ-New Jersey Dental School, 185 South Orange Avenue, Newark, New Jersey 07103-2400, USA.
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Gries
authors.forename: George A
authors.initials: GA
authors.lastname: Condouris
authors.forename: Zia
authors.initials: Z
authors.lastname: Shey
authors.forename: Milton
authors.initials: M
authors.lastname: Houpt
mesh_terms: D000284:Administration, Oral; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D003975:Diazepam / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009609:Nitrous Oxide / Q000494:pharmacology*; D014229:Triazolam / Q000494:pharmacology*
chemical_list: D014151:Anti-Anxiety Agents; D014229:Triazolam; D009609:Nitrous Oxide; D003975:Diazepam